An Aging-Related lncRNA Signature Establishing for Breast Cancer Prognosis and Immunotherapy Responsiveness Prediction
Introduction Globally, the number of newly diagnosed cases (11.7%) of female breast cancer (BC) is about 2.3 million, surpassing lung cancer as the most prevalent malignancy.1 BC possesses metastatic heterogeneity and plasticity, with varying colonization …